スポンサーリンク
Antibiotics Laboratory, Discovery Research Institute, RIKEN | 論文
- Factumycin and Its New Derivative RK-1009 Enhance Threonine-phosphorylation of a 60-kDa Protein in Streptomyces griseus
- Inhibition of Telomerase Activity by Fungus Metabolites, CRM646-A and Thielavin B
- P-538 TOTAL SYNTHESIS OF PANEPOPHENANTHRIN AND BIOLOGICAL ACTIVITIES OF ITS DERIVATIVES
- P-65 BIOMIMETIC OXIDATIVE DIMERIZATION FORMING EPOXYTWINOL A AND ITS COMPUTATIONAL ANALYSIS
- RKTS-33, an Epoxycyclohexenone Derivative That Specifically Inhibits Fas Ligand-Dependent Apoptosis in CTL-Mediated Cytotoxicity
- Protein Phosphatase 2A Inhibitors, Phoslactomycins. Effects on the Cytoskeleton in NIH/3T3 Cells
- Reveromycin A Inhibits Antigen Receptor-mediated Antigen Presentation by B Lymphoma Cells via Its Effect on Intracellular Trafficking of the Antigen
- Identification of Saccharomyces cerevisiae Ribosomal Protein L3 as a Target of Curvularol, a G_1-Specific Inhibitor of Mammalian Cells
- Dephosphorylation of Bcl-2 by protein phosphatase 2A results in apoptosis resistance
- Heparanase as a molecular target of cancer chemotherapy
- Epoxyquinol B, a Fungal Metabolite with a Potent Antiangiogenic Activity
- Osteoclast-targeting small molecules for the treatment of neoplastic bone metastases
- Epoxyquinol B, a Naturally Occurring Pentaketide Dimer, Inhibits NF-κB Signaling by Crosslinking TAK1
- Bcl-2 Inhibits Calcineurin-mediated Fas Ligand Expression in Antitumor Drug-treated Baby Hamster Kidney Cells